Health Care Technology
Company Overview of IMS Health Holdings, Inc.
IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, pr...
83 Wooster Heights Road
Danbury, CT 06810
Founded in 1954
Key Executives for IMS Health Holdings, Inc.
Chairman, Chief Executive Officer and President
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice President
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Product Management
Total Annual Compensation: $410.0K
Senior Vice President of Information Offerings
Total Annual Compensation: $402.0K
Compensation as of Fiscal Year 2014.
IMS Health Holdings, Inc. Key Developments
IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology
Jun 22 15
IMS Health and Foundation Medicine, Inc. announced a collaboration to advance the understanding and effectiveness of precision medicines for treating cancer. Commercial, medical and outcomes research teams in biopharma and life sciences companies will now be able to leverage an offering that combines IMS Health’s powerful Real-World Evidence platform providing clinical and cost-of-care insights with Foundation Medicine’s dynamic knowledgebase of comprehensive cancer genomic profiles, all at the patient-anonymous level. Through the collaboration, IMS Health’s clients will gain unprecedented insights to rapidly assess health outcomes and effectiveness, and to improve cancer care by better connecting patients to the right targeted therapies at the right time. These enhanced oncologic insights will be powered by Evidence 360 and FoundationCORE. Evidence 360 is IMS Health’s scalable and secure RWE platform that helps clients extract, analyze and visualize real-world data to better understand and measure healthcare outcomes. It brings together IMS Health’s vast library of patient-anonymous data with other patient-anonymous sources of health information to help life sciences companies interpret real-world outcomes and better target their commercial efforts. FoundationCORE is a molecular information knowledgebase containing comprehensive cancer genomic information and insights from more than 43,000 clinical cases profiled by Foundation Medicine. FoundationCORE evolves in real-time, informed by every new cancer patient tested with the company’s commercial assays, FoundationOne and FoundationOne Heme.
IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM
May 27 15
IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Ronald E. Bruehlman, Chief Financial Officer and Senior Vice President.
IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM
May 16 15
IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM. Venue: Corinthia Hotel, Saint Petersburg, Russia. Speakers: Nickolai Demidov, General Manager.
Similar Private Companies By Industry
Recent Private Companies Transactions